Jessica O'Driscoll
Psychiatric/Mental Health · Springfield, PANPI 1053846428
Payments from drug & device makers
Across 289 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$926
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$589
- Axsome Therapeutics, Inc.$364
- GSK$345
- Alkermes, Inc.$250
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,15998%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $2,053 |
| Otsuka America Pharmaceutical, Inc. | 37 | $926 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $589 |
| Axsome Therapeutics, Inc. | 14 | $364 |
| GSK | 19 | $345 |
| Alkermes, Inc. | 8 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $237 |
| Teva Pharmaceuticals USA, Inc. | 6 | $201 |
| Neurocrine Biosciences, Inc. | 11 | $178 |
| Novo Nordisk | 9 | $178 |
| Braeburn Inc. | 7 | $136 |
| Indivior Inc. | 5 | $114 |
| Lilly USA, LLC | 6 | $102 |
| Almatica Pharma LLC | 4 | $96 |
| Boehringer Ingelheim | 4 | $84 |
| Pfizer | 4 | $70 |
| AstraZeneca | 4 | $62 |
| Johnson & Johnson | 3 | $52 |
| Gilead | 3 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Orexo US, Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Abbott | 1 | $21 |
| Merck | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$236
- CAPLYTA$141
- REXULTI$136
- Auvelity$118
- ABILIFY ASIMTUFII$114
- ABILIFY MAINTENA$114
How this compares
$6,270 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 28 | $231,783 |
| RexultiBrexpiprazole | 12 | $26,121 |
| VraylarCariprazine Hcl | 11 | $14,748 |
| Aripiprazole | 73 | $5,604 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 23 | $5,570 |
| Clozapine | 40 | $2,608 |
| Quetiapine Fumarate | 86 | $1,483 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $1,190 |
| Lamotrigine | 45 | $948 |
| Duloxetine Hcl | 63 | $858 |
| Olanzapine | 28 | $731 |
| Clonazepam | 84 | $525 |
| Escitalopram Oxalate | 54 | $449 |
| Haloperidol | 24 | $448 |
| Trazodone Hcl | 44 | $417 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $178 | $231,78328 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $926 | $26,12112 claims |
| AbbVieVraylar | $2,053 | $14,74811 claims |
| Lilly USA, LLCOlanzapine | $102 | $73128 claims |
| Almatica Pharma LLCSertraline Hcl | $96 | $34133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
Other psychiatric/mental health in Springfield
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.